Connected & Ready podcast

How AI improves medicine from diagnosis to cure, with Chad Robins

Recuar 15 segundos
Avançar 15 segundos

Gemma Milne talks with Chad Robins, co-founder and CEO of Adaptive Biotechnologies, about his company’s work in the emerging field of immune medicine, how they use technology to drive innovation, and the potential for their work to create further advancements in the area of personalized medicine.

Topics of discussion

  • An overview of immune medicine (4:10)
  • An overview of Adaptive Biotechnologies’ T Detect antigen map (5:11)
  • The role of data and technologies such as machine learning in immune medicine (7:41)
  • Developing the T Detect COVID test (10:11)
  • How technology has shaped thinking around diagnostics and therapeutics (13:08)
  • Key diagnostic challenges (17:13)
  • Key treatment challenges (19:53)
  • The role of AI in furthering personalized medicine innovations (22:23)


About Chad Robins:

Since its founding in 2009, Chad has led Adaptive Biotechnologies in building a proprietary immune medicine platform that fuels businesses across life sciences research, clinical diagnostics, and drug discovery. Chad is routinely recognized for excellence and innovation. In 2019 and 2020, he was included in the Puget Sound Business Journal’s Power 100 and has been named a Goldman Sachs Most Intriguing Entrepreneur each year since 2015. He also named 2016 Ernst & Young Entrepreneur of the Year® – The Pacific Northwest Region Award.

Learn more:


Sponsor link

Dynamics 365 delivers next generation ERP and CRM business applications, helping employees at every level reason over data, predict trends, and make proactive, more-informed decisions. Request a live demo of Dynamics 365 today:


Contact us

Email: [email protected]


Follow us on social media




Mais episódios de "Connected & Ready"